Le Lézard
Classified in: Business
Subjects: TNM, MAT

CBD OF DENVER, INC. (CBDD) Acquires Swiss Cannabis Wholesale Operations


DENVER, June 22, 2020 /PRNewswire/ -- CBD of Denver, Inc. (OTC: CBDD), a full-line CBD and Hemp oil company ("CBDD") selling Black Pearl CBD and hemp products and the owner of CBD Social Network, is pleased to announce that CBDD has acquired Rockflowr GmbH, a Swiss cannabis wholesale operation.

CBD of Denver, Inc. is excited that it has taken another step towards its business goals and is proud to announce that it has acquired Rockflowr GmbH, a cannabis wholesale operation in Switzerland. This business is responsible for wholesale sales of CBD oil, cannabis biomass, cannabis flower and other products sold at retail outlets. These products are sold to retail and wholesale operations throughout the French, German, Italian and central parts of Switzerland as well as in EU countries that allow sales of CBD. The company is well positioned in these areas with successful on-going operations and has exclusive partnerships with cannabis farmers throughout the region. In the prior 3 months, Rockflowr has generated revenue of over 1,000,000 Swiss Francs (approximately US$1,040,000).  The company will also sell flower and biomass grown by our most recent acquisition, Welt 24 GmbH.  CBDD is now involved in all aspects of the Swiss cannabis business and is poised to take advantage of the expected growth in the Swiss cannabis market. 

CBDD's CEO, Marcel Gamma, explains, "We are very excited about this acquisition, which will add to our revenue base and contribute to future acquisitions. We expect to see increasing revenues from Rockflowr."

CBDD intends to continue their search for acquisition candidates in the Swiss CBD market. CBDD offers a superior CBD product that is full spectrum without depending on THC to activate the benefits of cannabidiol.  Black Pearl CBD has 0% THC, resulting in a product that is the finest in the industry.  Our lab is currently working with ICF Industries, Inc. (OTC:HTSC) to bring THC Free CBG and CBN to the market. Black Pearl CBD Sunscreen and new Black Pearl Products are available at www.blackpearlcbd.com.

Information contained herein includes forward-looking statements. These statements relate to future events or future financial performance, involving known and unknown risks and you should not place undue reliance on these statements. Any forward-looking statement reflects our current views with respect to future events. We assume no obligation publicly about update or revise these forward-looking statements for any reason.

 

SOURCE CBD of Denver, Inc.


These press releases may also interest you

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against SSR Mining...

at 22:45
Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until May 21, 2024 to file lead plaintiff applications in a securities class action lawsuit against Shoals...

at 22:10
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lincoln National Corporation ("Lincoln National" or "the Company") and certain of its...

at 21:29
TSX VENTURE COMPANIES BULLETIN V2024-1211 ALPHAMIN RESOURCES CORP.  ("AFM")BULLETIN TYPE:  Declaration of DividendBULLETIN DATE:  April 26, 2024TSX Venture Tier 2 Company The Issuer has declared the following dividend: Dividend Amount per Common...

at 21:22
Wall Financial Corporation (the "Company") released its operating results and financial statements for the three months and year  ended January 31, 2024.  The Company recorded net earnings and comprehensive income attributable to shareholders of the...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...



News published on and distributed by: